Petauri Health
A purpose-built pharmaceutical commercialization services platform that combines market access, health economics and outcomes research (HEOR), medical and scientific communications, payer and health system engagement, and digital analytics to accelerate patient access to therapies. The platform grows through organic development and acquisitions of specialist consultancies and agencies to provide end-to-end commercialization support for biopharmaceutical and medical device clients.
Industries
Nr. of Employees
small (1-50)
Petauri Health
Nashville, Tennessee; New York, New York (company offices referenced in site content)
Products
Medical and Scientific Communications
Service that transforms complex scientific data into clear communications for healthcare decision-makers.
Commercialization Insights and Access Strategy
Consulting service providing market access strategies and insights to optimize product adoption and access.
Global Pricing, Access and HEOR
Service focused on pricing, market access, and health economics and outcomes research to demonstrate product value.
Health System Services and Solutions
Service providing strategic advisory and marketing support tailored to health system dynamics and therapeutic areas.
Strategic Payer Market Access Marketing
Marketing service that develops payer-focused strategies to secure and expand market access.
Petauri Advisors - Market Access Consultancy
Consulting service offering market access research, pricing, and channel strategy to support life science commercialization.
Medical and Scientific Communications
Service that transforms complex scientific data into clear communications for healthcare decision-makers.
Commercialization Insights and Access Strategy
Consulting service providing market access strategies and insights to optimize product adoption and access.
Global Pricing, Access and HEOR
Service focused on pricing, market access, and health economics and outcomes research to demonstrate product value.
Health System Services and Solutions
Service providing strategic advisory and marketing support tailored to health system dynamics and therapeutic areas.
Strategic Payer Market Access Marketing
Marketing service that develops payer-focused strategies to secure and expand market access.
Petauri Advisors - Market Access Consultancy
Consulting service offering market access research, pricing, and channel strategy to support life science commercialization.
Services
KOL engagement, publications and abstracts, MSL training, conference strategy, disease awareness, and promotional/non-promotional scientific content for life sciences clients.
Strategy development for payer engagement, pricing, reimbursement, payer negotiation preparation and global pricing analysis.
End-to-end evidence strategy and generation including HEOR, real-world evidence studies, modeling, simulation, and evidence synthesis to support access and HTA.
Stakeholder engagement across health systems and integrated delivery networks to develop care pathways, treatment protocols, and adoption strategies.
Design and delivery of interactive budget impact models, digital toolkits, and value communication platforms to support payer engagement.
Specialist advisory on Medicaid programs, state policy, supplemental rebate negotiations, and public payer engagement strategies.
KOL engagement, publications and abstracts, MSL training, conference strategy, disease awareness, and promotional/non-promotional scientific content for life sciences clients.
Strategy development for payer engagement, pricing, reimbursement, payer negotiation preparation and global pricing analysis.
End-to-end evidence strategy and generation including HEOR, real-world evidence studies, modeling, simulation, and evidence synthesis to support access and HTA.
Stakeholder engagement across health systems and integrated delivery networks to develop care pathways, treatment protocols, and adoption strategies.
Design and delivery of interactive budget impact models, digital toolkits, and value communication platforms to support payer engagement.
Specialist advisory on Medicaid programs, state policy, supplemental rebate negotiations, and public payer engagement strategies.
Expertise Areas
- Market access strategy and payer engagement
- Health economics and outcomes research (HEOR)
- Real-world evidence (RWE) generation and analysis
- Medical and scientific communications
Key Technologies
- Health economic modeling
- Budget impact analysis
- Price/volume and economically justifiable price (EJP) modeling
- Real-world data analytics
News & Updates
Announcement of platform formation in partnership with private equity to build a purpose-built pharmaceutical commercialization services platform.
Launch of an integrated medical communications platform combining multiple acquired agencies and defining service offerings across publications, KOL engagement, and digital strategy.
Initial strategic acquisition to add market access, access marketing, and medical affairs capabilities.
Expanded scientific and medical communications capability through acquisition of an established communications agency.
Added global market access and advanced health economic modeling capabilities, expanding global evidence services.
Added multiple specialist medical communications agencies to expand therapeutic coverage, including oncology and rare diseases.
Announcement of platform formation in partnership with private equity to build a purpose-built pharmaceutical commercialization services platform.
Launch of an integrated medical communications platform combining multiple acquired agencies and defining service offerings across publications, KOL engagement, and digital strategy.
Initial strategic acquisition to add market access, access marketing, and medical affairs capabilities.
Expanded scientific and medical communications capability through acquisition of an established communications agency.
Added global market access and advanced health economic modeling capabilities, expanding global evidence services.
Added multiple specialist medical communications agencies to expand therapeutic coverage, including oncology and rare diseases.